LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Oct 15, 2020
Product Development
Oct. 14 Quick Takes: FDA approves first Ebola therapy; plus Vertex tumbles after hours on AAT discontinuation
Updates on Russia’s latest COVID-19 vaccine approval and more
Read More
BioCentury
|
May 20, 2020
Product Development
Vir backs cross-reactive mAb strategy with preclinical potency data
Read More
BioCentury
|
Mar 27, 2020
Product Development
Fewer is better: master protocols need to replace the deluge of small, inadequate studies for COVID-19
Guest Commentary: Master protocols are urgently needed to expedite COVID-19 therapies
Read More
BioCentury
|
Mar 14, 2020
Product Development
AbCellera, Vir find partners for COVID-19 mAb manufacturing capacity
Two start-ups partner for COVID-19 mAb manufacturing muscle
Read More
BioCentury
|
Feb 5, 2020
Product Development
2019-nCoV drug discovery: HHS funds Regeneron mAbs and BenevolentAI deploys machine learning
Read More
BioCentury
|
Jan 23, 2020
Clinical News
Biopharma companies, academics, governments racing to develop medical countermeasures against novel coronavirus
Read More
BioCentury
|
Aug 27, 2019
Company News
Longtime FDA head of infectious diseases Cox joins Regeneron
Read More
BioCentury
|
Aug 13, 2019
Clinical News
Two Ebola therapies best ZMapp in Congo trial
Read More
BioCentury
|
Mar 1, 2019
Company News
Judge rules FDA's reasoning for compassionate use exempt from FOIA requests
Read More
BioCentury
|
Nov 30, 2018
Clinical News
Fauci details goals of new Ebola trial
Read More
Items per page:
10
1 - 10 of 44
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help